Illinois Medicine

Volume 23 - Fall 2022

Issue link: https://www.e-digitaleditions.com/i/1478887

Contents of this Issue

Navigation

Page 2 of 55

G GREATER PATIENT SAFETY is a common motivator in healthcare education. That should come as no surprise. It also should come as no surprise that simulation continues to gain traction across medical education. We now even have an entire week each year in September dedicated to healthcare simulation, a worldwide effort put on by the Society for Simulation in Healthcare. Thanks to simulation, at no other time in history have we been so able to give learners the tools they need for developing clinical skills at no risk to patients. Healthcare education is no longer about see one, then do one, then teach one. It's about learners becoming the best clinicians they can through simulated experiences along with continued practice and expert feedback. That's the kind of safe learning environment we owe our learners and, ultimately, owe our patients and our community. Our cover story in this edition of Illinois Medicine takes a deeper look at the simulation opportunities available to our students and trainees at the University of Illinois College of Medicine. Facilities such as the Simulation and Integrative Learning (SAIL) Institute in Chicago, Jump Simulation at our Peoria campus, and the Surgical Innovation Training Laboratory (SITL) in Chicago are not just for education; they are places where we can test our ideas and innovations. Also in this edition, we look at the impact of COVID-19 more than two years after the pandemic changed our lives, delving into the impact on research, clinical care and medical education here at the College of Medicine. It has indeed been a rollercoaster ride, one we will continue to manage for the foreseeable future. In another feature article, we explore the College of Medicine's long relationship with the Jesse Brown Veterans Affairs Medical Center. The historic partnership dates to the final days of World War II and has since become a model for patient care, education and translational research. It's a special relationship that develops between the veterans, trainees and staff. And it's a partnership we are so very proud of here at the College. From a research perspective, the development of the Shingrix vaccine at the College of Medicine Rockford campus has proved to be a remarkable success in preventing shingles in adults over the age of 50 as well as immunocompromised adults over the age of 19. Shingrix has proven to be 97 percent effective at preventing shingles, an incredible outcome that will impact millions of lives. And that is our calling here at the College of Medicine, impacting lives and advancing health for everyone. Illinois Medicine | 1 Mark I. Rosenblatt, MD, PhD, MBA, MHA Executive Dean P H O T O : D I A N E S M U T N Y dean's message

Articles in this issue

Archives of this issue

view archives of Illinois Medicine - Volume 23 - Fall 2022